Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens.
Saved in:
| Title: | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. |
|---|---|
| Authors: | Alba C; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Malhotra S; IAVI, New York, New York, United States of America., Horsfall S; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Barnhart ME; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., Bekker A; Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Chapman K; IAVI, New York, New York, United States of America., Cunningham CK; Department of Pediatrics, University of California Irvine, Irvine, California, United States of America.; Department of Pediatrics, Children's Hospital of Orange County, Orange, California, United States of America., Fast PE; IAVI, New York, New York, United States of America.; Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, United States of America., Fouda GG; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America., Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Goga A; South African Medical Research Council, Cape Town, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Ghazaryan LR; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., Leroy V; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Inserm and Université Toulouse III, Toulouse, France., Mann C; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., McCluskey MM; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., McFarland EJ; Department of Pediatrics, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Muturi-Kioi V; Eastern Africa Regional Office, IAVI, Nairobi, Kenya., Permar SR; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America., Shapiro R; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Sok D; IAVI, New York, New York, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Stranix-Chibanda L; Child and Adolescent Health Unit, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe., Weinstein MC; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Ciaranello AL; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Dugdale CM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. |
| Source: | PloS one [PLoS One] 2025 Mar 19; Vol. 20 (3), pp. e0318940. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40106399 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alba+C%22">Alba C</searchLink>; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Malhotra+S%22">Malhotra S</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Horsfall+S%22">Horsfall S</searchLink>; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Barnhart+ME%22">Barnhart ME</searchLink>; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Bekker+A%22">Bekker A</searchLink>; Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Chapman+K%22">Chapman K</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Cunningham+CK%22">Cunningham CK</searchLink>; Department of Pediatrics, University of California Irvine, Irvine, California, United States of America.; Department of Pediatrics, Children's Hospital of Orange County, Orange, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+PE%22">Fast PE</searchLink>; IAVI, New York, New York, United States of America.; Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Fouda+GG%22">Fouda GG</searchLink>; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Freedberg+KA%22">Freedberg KA</searchLink>; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Goga+A%22">Goga A</searchLink>; South African Medical Research Council, Cape Town, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa.<br /><searchLink fieldCode="AU" term="%22Ghazaryan+LR%22">Ghazaryan LR</searchLink>; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Leroy+V%22">Leroy V</searchLink>; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Inserm and Université Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Mann+C%22">Mann C</searchLink>; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22McCluskey+MM%22">McCluskey MM</searchLink>; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22McFarland+EJ%22">McFarland EJ</searchLink>; Department of Pediatrics, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.<br /><searchLink fieldCode="AU" term="%22Muturi-Kioi+V%22">Muturi-Kioi V</searchLink>; Eastern Africa Regional Office, IAVI, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Permar+SR%22">Permar SR</searchLink>; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Shapiro+R%22">Shapiro R</searchLink>; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Sok+D%22">Sok D</searchLink>; IAVI, New York, New York, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Stranix-Chibanda+L%22">Stranix-Chibanda L</searchLink>; Child and Adolescent Health Unit, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Weinstein+MC%22">Weinstein MC</searchLink>; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Ciaranello+AL%22">Ciaranello AL</searchLink>; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Dugdale+CM%22">Dugdale CM</searchLink>; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2025 Mar 19; Vol. 20 (3), pp. e0318940. <i>Date of Electronic Publication: </i>2025 Mar 19 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40106399 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0318940 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0318940 Titles: – TitleFull: Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alba C – PersonEntity: Name: NameFull: Malhotra S – PersonEntity: Name: NameFull: Horsfall S – PersonEntity: Name: NameFull: Barnhart ME – PersonEntity: Name: NameFull: Bekker A – PersonEntity: Name: NameFull: Chapman K – PersonEntity: Name: NameFull: Cunningham CK – PersonEntity: Name: NameFull: Fast PE – PersonEntity: Name: NameFull: Fouda GG – PersonEntity: Name: NameFull: Freedberg KA – PersonEntity: Name: NameFull: Goga A – PersonEntity: Name: NameFull: Ghazaryan LR – PersonEntity: Name: NameFull: Leroy V – PersonEntity: Name: NameFull: Mann C – PersonEntity: Name: NameFull: McCluskey MM – PersonEntity: Name: NameFull: McFarland EJ – PersonEntity: Name: NameFull: Muturi-Kioi V – PersonEntity: Name: NameFull: Permar SR – PersonEntity: Name: NameFull: Shapiro R – PersonEntity: Name: NameFull: Sok D – PersonEntity: Name: NameFull: Stranix-Chibanda L – PersonEntity: Name: NameFull: Weinstein MC – PersonEntity: Name: NameFull: Ciaranello AL – PersonEntity: Name: NameFull: Dugdale CM IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 03 Text: 2025 Mar 19 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 20 – Type: issue Value: 3 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |